Attention Deficit Hyperactivity Disorder Clinical Trial
Official title:
A Follow-up, Family Study on Attention-deficit Hyperactivity Disorder
| Verified date | April 2012 |
| Source | National Taiwan University Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Taiwan: Department of Health |
| Study type | Observational |
Background: Attention deficit hyperactivity disorder (ADHD), characterized by inattention,
hyperactivity and impulsivity, is an early onset, common (5-10% worldwide; 7.5% in Taiwan),
clinically heterogeneous, impairing disorder. Despite the abundance of research on ADHD, the
vast majority of samples have been limited to Caucasians; there is limited information about
the expressions, patterns, correlates, and outcomes for ADHD in the Taiwanese population.
Specific Aims:
1. to investigate the neuropsychological functioning, and psychiatric, academic, and
social outcomes of ADHD at adolescence;
2. to examine the psychopathology and neuropsychological functioning among parents and
siblings of ADHD probands;
3. to determine the components of ADHD and neuropsychological functioning with the
greatest familial recurrence risks; and
4. to validate the classification of ADHD and comorbid subtypes of ADHD using
psychosocial, familial, neuropsychological and longitudinal data.
Subjects and Methods: This 5-year proposal consists of two parts: (1) a 3 year-retrospective
cohort study and family study design; and (2) a 2 year-prospective cohort study design.
Several Chinese version of rating scales will be prepared in the first 6 months. The sample
will consist of probands with (n=180) and without (n=90) ADHD, ages 11-16, recruited from
the Children's Mental Health Center, NTUH and an epidemiological study. The ADHD diagnosis
has been made 3-6 years ago prior to recruitment. Probands and their parents will be
assessed using the following measures (n=810) in the first 3 years. Only probands will be
reassessed in the last 2 years. The measures will include a psychiatric interview using
K-SADS-E and self-reports covering the individual and familial/environmental domains; and
neuropsychological tests (WISC-III, CPT, WCST, CANTAB). The informants include probands and
their parents and teachers.
Long-term Objectives: The long-term objectives are to identify the endophenotypes that are
close to the biological expression of genes underlying ADHD, to determine the familial
aggregation and its specificity regarding the components of ADHD, and neuropsychological
deficit, and to identify the impact of ADHD on academic, psychiatric, family, and social
outcomes; and to identify a cohort of families with ADHD for future neuroimaging,
neurophysiological, and molecular genetic studies.
| Status | Completed |
| Enrollment | 1800 |
| Est. completion date | December 2009 |
| Est. primary completion date | |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 10 Years to 18 Years |
| Eligibility |
Inclusion Criteria: - Community-based sample for the development of several Chinese versions of instruments: SNAP-IV, SDQ, ASRI, and ASRS. - ADHD follow-up family studies (ADHD group): (1) that subjects either had the clinical diagnosis of DSM-IV ADHD, which was made by a full-time child psychiatrist at the first visit and following visits or by a child psychiatrist using the K-SADS-E as the second-stage case ascertainment at an epidemiological study; (2) the diagnoses of ADHD were made 3-6 years ago; (3) their ages range from 12 to 15 when we conduct study; (4) subjects have at least one sibling aged 6-18 and live with at least one biological parent; and (5) subjects and their family consent to participate in this study. - (control group)(1) that subjects were assessed either at a clinical setting or in an epidemiological study same as to those in the exposed group 6 years ago; (2) their ages range from 12 to 15 when we conduct study; (3) subjects have at least one sibling aged 6-18 and live with at least one biological parent; and (4) subjects and their family consent to participate in this study. Exclusion Criteria: - The subjects, including those who in the exposed and unexposed groups, will be excluded from the study if they currently meet criteria or have a history of the following condition as defined by DSM-IV: Schizophrenia, Schizoaffective Disorder, Organic Psychosis, Mental Retardation, or Pervasive Developmental Disorder. Moreover, the subjects will be excluded from the unexposed group if have a history of the following condition as defined by DSM-IV: ADHD, ODD, or CD in addition to the above exclusion criteria. |
Observational Model: Case Control
| Country | Name | City | State |
|---|---|---|---|
| Taiwan | National Taiwan Univeristy Hospital | Taipei |
| Lead Sponsor | Collaborator |
|---|---|
| National Taiwan University Hospital | National Health Research Institutes, Taiwan |
Taiwan,
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06129396 -
Effects of Aerobic Exercise Intervention in Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)
|
N/A | |
| Completed |
NCT04779333 -
Lifestyle Enhancement for ADHD Program 2
|
N/A | |
| Recruiting |
NCT05935722 -
Evaluation of a Home-based Parenting Support Program: Parenting Young Children
|
N/A | |
| Completed |
NCT03148782 -
Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase
|
N/A | |
| Completed |
NCT04832737 -
Strength-based Treatment Approach for Adults With ADHD
|
N/A | |
| Recruiting |
NCT04631042 -
Developing Brain, Impulsivity and Compulsivity
|
||
| Recruiting |
NCT05048043 -
Development of a Game-supported Intervention
|
N/A | |
| Completed |
NCT03337646 -
Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism
|
Phase 4 | |
| Not yet recruiting |
NCT06454604 -
Virtual Reality Treatment for Emerging Adults With ADHD
|
Phase 2 | |
| Not yet recruiting |
NCT06406309 -
Settling Down for Sleep in ADHD: The Impact of Sensory and Arousal Systems on Sleep in ADHD
|
N/A | |
| Not yet recruiting |
NCT06080373 -
Formulation-based CBT for Adult Inmates With ADHD: A Randomized Controlled Trial
|
N/A | |
| Completed |
NCT02911194 -
a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD)
|
N/A | |
| Completed |
NCT02477280 -
Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance
|
Phase 4 | |
| Completed |
NCT02555150 -
A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD
|
Phase 3 | |
| Completed |
NCT02390791 -
New Technologies to Help Manage ADHD
|
N/A | |
| Completed |
NCT02473185 -
Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the QbTest
|
Phase 4 | |
| Completed |
NCT02829970 -
Helping College Students With ADHD Lead Healthier Lifestyles
|
N/A | |
| Completed |
NCT02780102 -
Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD
|
N/A | |
| Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
| Recruiting |
NCT04175028 -
Neuromodulation of Executive Function in the ADHD Brain
|
N/A |